SAN DIEGO,
Feb. 7, 2018 /PRNewswire/ --
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology
innovation, focused on transforming spine surgery with minimally
disruptive, procedurally-integrated solutions, announced today that
its fourth quarter and full year 2017 earnings announcement will
take place on Monday, February 26,
2018, after the close of the market.
NuVasive will hold a conference call on Monday,
February 26, 2018, at 4:30 p.m. ET / 1:30 p.m.
PT to discuss the results of its financial performance for the
fourth quarter and full year 2017. The dial-in numbers are
1-877-407-9039 for domestic callers and 1-201-689-8470 for
international callers. A live webcast of the conference call will
be available online from the Investor Relations page of the
Company's website
at www.nuvasive.com.
After the live webcast, the call will remain available
on NuVasive's website through March 26, 2018. In
addition, a telephone replay of the call will be available
until March 5, 2018. The replay dial-in numbers are
1-844-512-2921 for domestic callers and 1-412-317-6671 for
international callers. Please use pin number: 13675438.
About NuVasive
NuVasive, Inc.
(NASDAQ: NUVA) is the leader in spine technology innovation,
focused on transforming spine surgery and beyond with minimally
disruptive, procedurally-integrated solutions designed to deliver
reproducible and clinically-proven surgical outcomes. The Company's
portfolio includes access instruments, implantable hardware,
biologics, software systems for surgical planning, navigation and
imaging solutions, magnetically adjustable implant systems for
spine and orthopedics, and intraoperative monitoring service
offerings. With $962 million in
revenues (2016), NuVasive has an approximate 2,300 person workforce
in more than 40 countries serving surgeons, hospitals and patients.
For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could cause NuVasive's results to
differ materially from historical results or those expressed or
implied by such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, but are not limited to, the risk that
NuVasive's revenue or earnings projections may turn out to be
inaccurate because of the preliminary nature of the forecasts; the
risk of further adjustment to financial results or future financial
expectations; unanticipated difficulty in selling products,
generating revenue or producing expected profitability; and those
other risks and uncertainties more fully described in NuVasive's
news releases and periodic filings with the Securities and Exchange
Commission. NuVasive's public filings with the Securities and
Exchange Commission are available at www.sec.gov. NuVasive assumes
no obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-fourth-quarter-and-full-year-2017-results-300594661.html
SOURCE NuVasive, Inc.